Get App Open
In App
Lending
Lending
Open App
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 03, 16:01
1977.80 19.15 (0.98%)
Volume
AVERAGE VOLUME
5-Day
21,261
10-Day
26,739
30-Day
20,867
7,971
  • Prev. Close

    1958.65

  • Open Price

    1946.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 03, 15:56
1980.20 21.00 (1.07%)
Volume
AVERAGE VOLUME
5-Day
671,857
10-Day
693,655
30-Day
712,493
419,687
  • Prev. Close

    1959.20

  • Open Price

    1959.20

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1980.20 (88)

Financials

Profit & Loss account of Glenmark Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 6,491.20 6,131.14 6,096.05 7,694.83 5,906.97  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 87.91  
Revenue From Operations [Net] 6,491.20 6,131.14 6,096.05 7,694.83 5,819.06  
Total Operating Revenues 6,712.63 6,304.87 6,431.88 8,095.50 6,115.17  
Other Income 606.79 475.61 180.42 148.24 117.28  
Total Revenue 7,319.42 6,780.48 6,612.31 8,243.74 6,232.45  
EXPENSES  
Cost Of Materials Consumed 2,251.98 1,585.85 2,038.57 2,242.01 1,792.24  
Purchase Of Stock-In Trade 365.24 301.30 288.18 267.00 219.98  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade 48.77 471.81 51.85 -83.52 -73.55  
Employee Benefit Expenses 1,072.33 969.98 1,021.92 914.47 766.25  
Finance Costs 256.39 223.81 190.90 152.60 36.22  
Depreciation And Amortisation Expenses 138.54 106.28 118.20 104.93 99.81  
Other Expenses 1,670.08 1,648.45 1,683.87 1,856.90 1,644.97  
Total Expenses 5,803.33 5,307.48 5,393.48 5,454.39 4,485.92  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,516.09 1,473.00 1,218.83 2,789.35 1,746.53  
Exceptional Items 18.55 345.19 0.00 -236.45 0.00  
Profit/Loss Before Tax 1,534.64 1,818.18 1,218.83 2,552.90 1,746.53  
Tax Expenses-Continued Operations  
Current Tax 269.24 383.50 270.68 604.02 374.62  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -89.14 -53.61 -66.20 -191.74 -112.35  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 180.10 329.88 204.48 412.29 262.26  
Profit/Loss After Tax And Before ExtraOrdinary Items 1,354.55 1,488.30 1,014.35 2,140.61 1,484.27  
Profit/Loss From Continuing Operations 1,354.55 1,488.30 1,014.35 2,140.61 1,484.27  
Profit/Loss For The Period 1,354.55 1,622.11 1,014.35 2,140.61 1,484.27  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 48.00 57.49 35.95 75.86 52.87  
Diluted EPS (Rs.) 48.00 57.49 35.94 75.84 52.86  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 386.60  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 1,347.96  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 56.01  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 68.03 68.03 67.92 67.95 67.92  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 250.00 200.00 200.00 200.00 200.00  
Source : Dion Global Solutions Limited

Results of Glenmark